Differential resistance to antiviral drugs in an immunocompromised patient with cytomegalovirus encephalitis.
Wada
Taizo
T
Mase
Shintaro
S
Shibata
Fumie
F
Shimizu
Masaki
M
Toma
Tomoko
T
Yachie
Akihiro
A
D000293:Adolescent; D019943:Amino Acid Substitution / Q000235:genetics; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000821:virology*; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D004259:DNA-Directed DNA Polymerase / Q000235:genetics; D018792:Encephalitis, Viral / Q000188:drug therapy* / Q000821:virology*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D020125:Mutation, Missense; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics; D017422:Sequence Analysis, DNA; D014764:Viral Proteins / Q000235:genetics
D000998:Antiviral Agents; D004279:DNA, Viral; C109367:UL54 protein, Human herpesvirus 5; D014764:Viral Proteins; D017853:Phosphotransferases (Alcohol Group Acceptor); C075365:ganciclovir kinase; D004259:DNA-Directed DNA Polymerase